BD Diagnostics said this week that it has filed for 510(k) clearance with the US Food and Drug Administration for its BD ProbeTec HSV-1 and HSV-2 Qx Amplified DNA assays.

The assays will run on the BD Viper system with XTR technology, which uses strand displacement amplification to qualitatively detect and differentiate herpes simplex virus I and II DNA in clinician-collected external anogenital lesion specimens.

BD said that its tests will allow laboratories to read up to 96 positive or negative results in about two and a half hours

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Genome Research this week: multiplex genotyping of germline and somatic short tandem repeats, graph-based regularization, and more.

A lack of funding may lead more than two dozen research facilities in Australia to shut down in three months.

Researchers report that paternally inherited genes are more likely to be expressed in mice.

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.